Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. Our lead molecule, azetukalner, is a novel, potent, selective Kv7 potassium channel opener in Phase 3 clinical trials for the treatment of epilepsy, major depressive disorder (MDD) and bipolar depression (BPD). We are also advancing an early-stage portfolio of multiple promising potassium and sodium channel modulators, including Kv7 and Nav1.7 programs in Phase 1 development for the potential treatment of pain. We have offices in Vancouver, British Columbia, and Boston, Massachusetts.
- Founded
- 1996
- Company size
- 201-500
- Headquarters
- Burnaby, British Columbia, CA
- Funding
- Post Ipo Equity
Hiring activity
- Open roles
- 9
- Posted in the last 30 days
- 10
Updated 9h ago
What Xenon Pharmaceuticals says about its culture
What Xenon Pharmaceuticals says it offers, drawn from its own website.
Check if you fitOpens the career fit test.
We're on a mission to deliver innovative medicines to provide a brighter future for people living with neurological and psychiatric disorders.
Diversity
“We cultivate and celebrate diversity in our company, as we view diverse backgrounds, experiences, and opinions as a great asset.”Source
Flexibility
“We also value flexibility in how and where we work and provide a stipend for work-from-home setups to ensure comfort and productivity”Source
They say people do well here who…
- Driven by passion and scientific curiosity
- Values collaboration, creativity, and a commitment to making a positive impact
Quoted from Xenon Pharmaceuticals's own website. TeaKo does not verify these claims.
Latest openings
9 open roles at Xenon Pharmaceuticals. Members see each one.
